Australian stingless bee honey shows promise against antibiotic-resistant bacteria

Researchers at Australia's University of Sydney are investigating the therapeutic potential of honey produced by stingless bees as a possible tool in the fight against antimicrobial resistance, one of the world's most pressing public health challenges.

In laboratory testing, the honey—known locally as sugarbag honey—has demonstrated effectiveness against multiple bacterial and fungal pathogens, including strains that resist conventional antibiotic treatments. The findings indicate that the honey's antimicrobial strength is comparable to established medical-grade honey varieties already used in clinical settings.

The research team also examined propolis, the resinous substance bees produce, though results showed selective rather than broad-spectrum antimicrobial activity. Scientists have not yet identified which specific compounds within the honey are responsible for its potency against resistant pathogens.

The investigation comes as antibiotic resistance poses an escalating threat to global health systems. With conventional treatments becoming increasingly ineffective, researchers worldwide are exploring alternative therapeutic options, including natural products with documented antimicrobial properties.

The University of Sydney team plans to conduct further studies to isolate and characterize the active ingredients in stingless bee honey, potentially opening new avenues for treating infections resistant to standard antibiotics.